Molecular Engineering of Viral-Like Particles for Targeted Therapeutic Applications
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Microbiology".
Deadline for manuscript submissions: 30 April 2025 | Viewed by 22
Special Issue Editor
Interests: computational biophysics; precision medicine; targeted therapies; drug design and development
Special Issue Information
Dear Colleagues,
The study of virus-like particles (VLPs) has unlocked exciting possibilities in targeted therapeutic applications by leveraging the structural properties of viruses—without their infectious components. By harnessing the precision and efficiency of viral mechanisms, researchers aim to create powerful delivery vehicles for a wide array of therapeutics, ranging from small-molecule drugs to complex gene therapies.
This innovative field represents a significant leap forward in molecular engineering, merging insights from virology, nanotechnology, biomedicine, and computational biophysics to overcome key challenges in drug delivery, specificity, and off-target effects. With potential applications in oncology, infectious diseases, and gene therapy, VLP technology holds promise for creating more effective and safer treatments.
We invite original research papers, perspectives, and reviews for this Special Issue, which will showcase the latest advances in VLP design and lay the groundwork for future breakthroughs in precision medicine.
Dr. Rita P. Melo
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- virus-like particles (VLPs)
- targeted drug delivery
- molecular engineering
- precision medicine
- gene therapy
- nanotechnology
- biomedicine
- computational biophysics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
